Dr. Dan Safarpour received a B.S. in Chemistry in 1991 from the University of Arkansas, Fayetteville and a Ph.D. in Environmental Analytical Chemistry in 2001 from Rutgers University, Cook College, New Brunswick, New Jersey. Dr. Dan Safarpour started his professional career as residue chemist atAltheimer Laboratory of the University of Arkansas in Fayetteville, Arkansas. In 1993, he began employment with American Cyanamid Company, Princeton, New Jersey as an Analytical Chemist in the Toxicology Analysis laboratory. Later, within Cyanamid Global Research Center, he moved to other research group called Metabolism, Residue, Environmental Fate and Eco-Toxicology (MREE) Group as a Residue Chemist/Study Director. In 2000, American Cyanamid Company was acquired by BASF Corporation, at which time he joined the Formulations Analysis Group. In September 2001, he joined Taxolog, Inc, a pharmaceutical/biotechnology startup company. As a group leader at Taxolog, he was brought on-board to build an analytical group capable of conducting formulations analysis support as well as metabolism and bioanalytical to determine metabolite structures to protect company IP on pharmaceutically active metabolites and co-drugs. Dr. Safarpour led his team in compiling analytical R&D and dossier preparation for filing several IND, CTX and aNDA in partnership with Pfizer corporation. Dr. Safarpour has been published in journals such as Journal of Pharmaceutical and Biomedical Analysis (JPBA), Journal of Chromatography, Electrophoresis, Journal of Associations of Officials in Analytical Chemistry (JAOAC) and Journal of Pesticide Science. Per invitation from US-EPA regulatory bodies, Dr. Safarpour has contributed a chapter on Application of Capillary Electrophoresis to Pesticide Analysis to the Encyclopedia of Agrochemicals. Dr. Safarpour has given numerous oral presentations in national and international conferences in the areas of separation sciences, process and formulations analysis, human and plant metabolism, bioanalytical, and residue chemistry. His presentations have focused on the use of cutting-edge technologies such as UPLC, HPLC, CE, and GC, as well as UPLC-MS-QTOF, HPLC-MS-Triple Quad platforms and CE-MS. Dr. Safarpour has chaired symposium in peptide-protein friendly instrumentations arena, judged poster presentations at ACS functions such as the Triangle Chromatography Discussion Group (TCDG). Since 2003 until 2015, Dr. Safarpour has served on the peer review committee for prestigious journals such as JPBA, JAOAC and Electrophoresis. In early 2009, Dr. Safarpour, with former colleagues, employees founded a new life sciences contract research organization called Symbiotic Research, LLC. In 2017, he sold Symbiotic Research to a German conglomerate-Tentamus GmbH. In 2018, together with Tentamus GmbH, Dr. Safarpour acquired animal research facility Genesis Midwest, LLC out of Wisconsin USA to enable Symbiotic Research to provide in-life and analytical package study services to its global Animal Health and Agrochemical clients. In 2014, Dr. Safarpour was hired by International Atomic Energy Agency (IAEA) Food Safety division as an “Expert Lecturer” to consult the agency by traveling to developing countries and guiding the subject nations on matters related to building laboratories and laboratory infrastructures capable of analyzing agricultural food products by LCMS and ultimately helping those nations to be able to export their raw agricultural products globally in an attempt to expand their GDP growth and aid in global food sustainability.
